Annals of Occupational Hygiene Advance Access published online on August 26, 2005
Annals of Occupational Hygiene, doi:10.1093/annhyg/mei045
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 University of Pharmacy Paris 5 René Descartes, Pharmacie Galénique, 4 avenue de l'Observatoire 75006 Paris, France; CHI Saint Germain-en-Laye, Pharmacy department, 20, rue Armagis, 78105 Saint Germain-en-Laye, France; GERPAC (Group of Evaluation and Research for Protection in Controlled Area), ZI de saux, 6 rue Ampère, 65100 Lourdes, France
* To whom correspondence should be addressed. Occupational exposure to cytotoxic drugs of hospital personnel involved in their preparation and administration is a major issue: ever since the introduction of protective measures in recent decades, the handling of these drugs has always been referred to as an occupational health hazard. Isolator technology was one of the protective equipments aimed at providing safe handling, but it has not yet been studied regarding contamination. The present study evaluates surface contamination with four cytotoxic drugs [cyclophosphamide (CP), ifosfamide (IF), 5 fluorouracil (5FU) and methotrexate (MTX)] by wipe sampling in two hospital pharmacies. Wipe samples were taken from work surfaces both located inside and outside the isolators. In addition, working gloves, the surface of infusion bags filled with 5FU or CP, and gloves used in simulation of drug administration were analyzed. Contamination was routinely found inside the isolators but rarely outside the isolators, indicating that the isolator technology is offering good protection of the cytotoxic drug handlers as well as the environment during preparation. On the other hand, contamination was found on the surfaces of infusion bags and gloves in contact with infusion bags filled with cytotoxic drugs. Consequently, personal protective equipment is still recommended during the manipulation and administration of the drugs because of potentially contaminated drug vials and final products.
Received April 20, 2005
Accepted July 9, 2005
Article
Environmental Contamination with Cytotoxic Drugs in Healthcare Using Positive Air Pressure Isolators
2 Exposure Control B.V., P.O. Box 467, 6600, AL Wijchen, The Netherlands
3 CH Pau, Pharmacy department, 4 bd Hauterive, 64000, Pau, France; GERPAC (Group of Evaluation and Research for Protection in Controlled Area), ZI de saux, 6 rue Ampère, 65100 Lourdes, France
S. Crauste-Manciet, E-mail: sylvie.crauste-manciet{at}univ-paris5.fr
Abstract 
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  R. Schierl, A. Bohlandt, and D. Nowak Guidance Values for Surface Monitoring of Antineoplastic Drugs in German Pharmacies Ann. Hyg., October 1, 2009; 53(7): 703 - 711. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Touzin, J.-F. Bussieres, E. Langlois, and M. Lefebvre Evaluation of surface contamination in a hospital hematology--oncology pharmacy Journal of Oncology Pharmacy Practice, March 1, 2009; 15(1): 53 - 61. [Abstract] [PDF]
|
|
|
|
 |
|
 B. Bonan, N. Martelli, M. Berhoune, M.-L. Maestroni, L. Havard, and P. Prognon The application of hazard analysis and critical control points and risk management in the preparation of anti-cancer drugs Int. J. Qual. Health Care, February 1, 2009; 21(1): 44 - 50. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Touzin, J.-F. Bussieres, E. Langlois, M. Lefebvre, and C. Gallant Cyclophosphamide Contamination Observed on the External Surfaces of Drug Vials and the Efficacy of Cleaning on Vial Contamination Ann. Hyg., November 1, 2008; 52(8): 765 - 771. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Nygren, E. Olofsson, and L. Johansson Spill and Leakage Using a Drug Preparation System Based on Double-Filter Technology Ann. Hyg., March 1, 2008; 52(2): 95 - 98. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Section 1 Introduction Journal of Oncology Pharmacy Practice, September 1, 2007; 13(3_suppl): 3 - 6. [PDF]
|
|
|
|
 |
|
 J.-F. Bussieres, Y. Theoret, S. Prot-Labarthe, and D. Larocque Program to monitor surface contamination by methotrexate in a hematology-oncology satellite pharmacy Am. J. Health Syst. Pharm., March 1, 2007; 64(5): 531 - 535. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. H. Connor and M. A. McDiarmid Preventing Occupational Exposures to Antineoplastic Drugs in Health Care Settings CA Cancer J Clin, November 1, 2006; 56(6): 354 - 365. [Abstract] [Full Text] [PDF]
|
|